Standardized staining procedures for histopathology are the gold standard to reveal ectopic calcifications. Typically, tissue samples are taken from patients and stained for examination by pathologists. Several publications have underlined the limitations of this procedure. Bonnewald et al [ Bonewald L F, Harris S E, Rosser J, Dallas M R, Dallas S L, Camacho N P, Boyan B and Boskey A 2003 Calcif. Tissue Int. 72 537–47] demonstrated that staining procédures such as von Kossa staining alone is not appropriate for identifying and quantifying apatite. Identification can be completed by other techniques routinely used in some cases: Fourier transform infrared (FTIR)61 and Raman spectroscopy.
In fact, crystals are found in kidney biopsies performed in order to understand the mechanism of the loss of renal function. However, only few histochemical tests are available to attempt an identification of the crystals. Moreover, in some cases, common crystals such as calcium oxalate monohydrate may be present as a consequence of renal failure, but they are not involved in the kidney loss. For these reasons, it is of clinical importance to accurately identify crystals found in the tissue as they can help to early characterization of a disease,
In a recent investigation, new crystalline phases were described such as amorphous silica, sodium hydrogen urate, methyl-1 uric acid and three different Ca2+ phosphates namely whitlockite, OCP and ACCP. Moreover, for the first time, we underline the chemical heterogeneity of intratissular calcifications.
Note that Dihydroxyadenine crystals were found in four patients (five biopsies in Table 1). Such crystals deposits in parenchyma are pathognomonic of a rare disease, adenine phosphoribosyltransferase deficiency, an inherited disease able to induce recurrent kidney stones and/or kidney failure. Dihydroxyadenine is often too late identified in patients who have developedrenal insufficiency and sometimes after the crystal-induced destruction of a kidney transplant.